Copyright Reports & Markets. All rights reserved.

Global Tumor Genomics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Assays and Kits
    • 1.2.3 Instrument
  • 1.3 Market by Application
    • 1.3.1 Global Tumor Genomics Market Share by Application: 2020 VS 2026
    • 1.3.2 Diagnostics and Monitoring
    • 1.3.3 Drug Discovery and Development
    • 1.3.4 Biomarker Discovery
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Tumor Genomics Market Perspective (2015-2026)
  • 2.2 Global Tumor Genomics Growth Trends by Regions
    • 2.2.1 Tumor Genomics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Tumor Genomics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Tumor Genomics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Tumor Genomics Players by Market Size
    • 3.1.1 Global Top Tumor Genomics Players by Revenue (2015-2020)
    • 3.1.2 Global Tumor Genomics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Tumor Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Tumor Genomics Revenue
  • 3.4 Global Tumor Genomics Market Concentration Ratio
    • 3.4.1 Global Tumor Genomics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2019
  • 3.5 Key Players Tumor Genomics Area Served
  • 3.6 Key Players Tumor Genomics Product Solution and Service
  • 3.7 Date of Enter into Tumor Genomics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Genomics Breakdown Data by Type (2015-2026)

  • 4.1 Global Tumor Genomics Historic Market Size by Type (2015-2020)
  • 4.2 Global Tumor Genomics Forecasted Market Size by Type (2021-2026)

5 Tumor Genomics Breakdown Data by Application (2015-2026)

  • 5.1 Global Tumor Genomics Historic Market Size by Application (2015-2020)
  • 5.2 Global Tumor Genomics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Tumor Genomics Market Size (2015-2026)
  • 6.2 North America Tumor Genomics Market Size by Type (2015-2020)
  • 6.3 North America Tumor Genomics Market Size by Application (2015-2020)
  • 6.4 North America Tumor Genomics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Tumor Genomics Market Size (2015-2026)
  • 7.2 Europe Tumor Genomics Market Size by Type (2015-2020)
  • 7.3 Europe Tumor Genomics Market Size by Application (2015-2020)
  • 7.4 Europe Tumor Genomics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Tumor Genomics Market Size (2015-2026)
  • 8.2 China Tumor Genomics Market Size by Type (2015-2020)
  • 8.3 China Tumor Genomics Market Size by Application (2015-2020)
  • 8.4 China Tumor Genomics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Tumor Genomics Market Size (2015-2026)
  • 9.2 Japan Tumor Genomics Market Size by Type (2015-2020)
  • 9.3 Japan Tumor Genomics Market Size by Application (2015-2020)
  • 9.4 Japan Tumor Genomics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Tumor Genomics Market Size (2015-2026)
  • 10.2 Southeast Asia Tumor Genomics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Tumor Genomics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Tumor Genomics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Tumor Genomics Introduction
    • 11.1.4 Abbott Laboratories Revenue in Tumor Genomics Business (2015-2020))
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Agilent Technologies, Inc
    • 11.2.1 Agilent Technologies, Inc Company Details
    • 11.2.2 Agilent Technologies, Inc Business Overview
    • 11.2.3 Agilent Technologies, Inc Tumor Genomics Introduction
    • 11.2.4 Agilent Technologies, Inc Revenue in Tumor Genomics Business (2015-2020)
    • 11.2.5 Agilent Technologies, Inc Recent Development
  • 11.3 Bio-Rad Laboratories, Inc.
    • 11.3.1 Bio-Rad Laboratories, Inc. Company Details
    • 11.3.2 Bio-Rad Laboratories, Inc. Business Overview
    • 11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Introduction
    • 11.3.4 Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2015-2020)
    • 11.3.5 Bio-Rad Laboratories, Inc. Recent Development
  • 11.4 Danaher Corporation
    • 11.4.1 Danaher Corporation Company Details
    • 11.4.2 Danaher Corporation Business Overview
    • 11.4.3 Danaher Corporation Tumor Genomics Introduction
    • 11.4.4 Danaher Corporation Revenue in Tumor Genomics Business (2015-2020)
    • 11.4.5 Danaher Corporation Recent Development
  • 11.5 F. Hoffmann-La Roche Ltd
    • 11.5.1 F. Hoffmann-La Roche Ltd Company Details
    • 11.5.2 F. Hoffmann-La Roche Ltd Business Overview
    • 11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Introduction
    • 11.5.4 F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2015-2020)
    • 11.5.5 F. Hoffmann-La Roche Ltd Recent Development
  • 11.6 Fluidigm Corporation
    • 11.6.1 Fluidigm Corporation Company Details
    • 11.6.2 Fluidigm Corporation Business Overview
    • 11.6.3 Fluidigm Corporation Tumor Genomics Introduction
    • 11.6.4 Fluidigm Corporation Revenue in Tumor Genomics Business (2015-2020)
    • 11.6.5 Fluidigm Corporation Recent Development
  • 11.7 General Electric Company
    • 11.7.1 General Electric Company Company Details
    • 11.7.2 General Electric Company Business Overview
    • 11.7.3 General Electric Company Tumor Genomics Introduction
    • 11.7.4 General Electric Company Revenue in Tumor Genomics Business (2015-2020)
    • 11.7.5 General Electric Company Recent Development
  • 11.8 Illumina, Inc.
    • 11.8.1 Illumina, Inc. Company Details
    • 11.8.2 Illumina, Inc. Business Overview
    • 11.8.3 Illumina, Inc. Tumor Genomics Introduction
    • 11.8.4 Illumina, Inc. Revenue in Tumor Genomics Business (2015-2020)
    • 11.8.5 Illumina, Inc. Recent Development
  • 11.9 Merck KGaA
    • 11.9.1 Merck KGaA Company Details
    • 11.9.2 Merck KGaA Business Overview
    • 11.9.3 Merck KGaA Tumor Genomics Introduction
    • 11.9.4 Merck KGaA Revenue in Tumor Genomics Business (2015-2020)
    • 11.9.5 Merck KGaA Recent Development
  • 11.10 Myriad Genetics, Inc.
    • 11.10.1 Myriad Genetics, Inc. Company Details
    • 11.10.2 Myriad Genetics, Inc. Business Overview
    • 11.10.3 Myriad Genetics, Inc. Tumor Genomics Introduction
    • 11.10.4 Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2015-2020)
    • 11.10.5 Myriad Genetics, Inc. Recent Development
  • 11.11 Pacific Biosciences of California, Inc.
    • 10.11.1 Pacific Biosciences of California, Inc. Company Details
    • 10.11.2 Pacific Biosciences of California, Inc. Business Overview
    • 10.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Introduction
    • 10.11.4 Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2015-2020)
    • 10.11.5 Pacific Biosciences of California, Inc. Recent Development
  • 11.12 PerkinElmer
    • 10.12.1 PerkinElmer Company Details
    • 10.12.2 PerkinElmer Business Overview
    • 10.12.3 PerkinElmer Tumor Genomics Introduction
    • 10.12.4 PerkinElmer Revenue in Tumor Genomics Business (2015-2020)
    • 10.12.5 PerkinElmer Recent Development
  • 11.13 QIAGEN
    • 10.13.1 QIAGEN Company Details
    • 10.13.2 QIAGEN Business Overview
    • 10.13.3 QIAGEN Tumor Genomics Introduction
    • 10.13.4 QIAGEN Revenue in Tumor Genomics Business (2015-2020)
    • 10.13.5 QIAGEN Recent Development
  • 11.14 Siemens Healthineers AG
    • 10.14.1 Siemens Healthineers AG Company Details
    • 10.14.2 Siemens Healthineers AG Business Overview
    • 10.14.3 Siemens Healthineers AG Tumor Genomics Introduction
    • 10.14.4 Siemens Healthineers AG Revenue in Tumor Genomics Business (2015-2020)
    • 10.14.5 Siemens Healthineers AG Recent Development
  • 11.15 Thermo Fisher Scientific Inc.
    • 10.15.1 Thermo Fisher Scientific Inc. Company Details
    • 10.15.2 Thermo Fisher Scientific Inc. Business Overview
    • 10.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Introduction
    • 10.15.4 Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2015-2020)
    • 10.15.5 Thermo Fisher Scientific Inc. Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Tumor Genomics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Genomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Assays and Kits
    Instrument

    Market segment by Application, split into
    Diagnostics and Monitoring
    Drug Discovery and Development
    Biomarker Discovery

    Based on regional and country-level analysis, the Tumor Genomics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Tumor Genomics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Laboratories
    Agilent Technologies, Inc
    Bio-Rad Laboratories, Inc.
    Danaher Corporation
    F. Hoffmann-La Roche Ltd
    Fluidigm Corporation
    General Electric Company
    Illumina, Inc.
    Merck KGaA
    Myriad Genetics, Inc.
    Pacific Biosciences of California, Inc.
    PerkinElmer
    QIAGEN
    Siemens Healthineers AG
    Buy now